[Nephroprotection in young type 1 diabetic patients treated with converting enzyme inhibitor].
Benamar L, Laboudi A, Rhou H, Laouad I, Fahi Z, Bentata Y, Amar Y, Ezzaïtouni F, Ouzeddoun N, Bayahia R, Balafrej L, Touzani A, Benhamou B, Balafrej A, Guedira A.
Benamar L, et al. Among authors: balafrej a.
Presse Med. 2003 Apr 12;32(14):638-43.
Presse Med. 2003.
PMID: 12714902
Clinical Trial.
French.